Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction
Study objective – The aim of the study was to investigate the use of an optimised function to approximate and interpolate the time course of serum creatine kinase and creatine kinase-MB values after thrombolytic therapy in acute myocardial infarction. Design – A three parameter interpolating functio...
Gespeichert in:
Veröffentlicht in: | Cardiovascular research 1990-04, Vol.24 (4), p.328-334 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 334 |
---|---|
container_issue | 4 |
container_start_page | 328 |
container_title | Cardiovascular research |
container_volume | 24 |
creator | Schwerdt, Holger Özbek, Cem Fröhlig, Gerd Schieffer, Hermann Bette, Ludwig |
description | Study objective – The aim of the study was to investigate the use of an optimised function to approximate and interpolate the time course of serum creatine kinase and creatine kinase-MB values after thrombolytic therapy in acute myocardial infarction. Design – A three parameter interpolating function was developed which approximates the time course of serum enzyme levels. In the proposed function, time to peak creatine kinase and maximum of creatine kinase determined from raw data were used as starting parameters of the non-linear interpolation routine, thus providing ideal starting conditions for the iteration. The efficacy of the function was compared with that of three other functions cited in published reports (log-normal distribution function, modified gamma density function, three compartment function). Subjects – Serum enzyme data from 20 patients with acute myocardial infarction were used in the comparisons. The patients have all been treated with anisoylated plasminogen streptokinase activator complex. Results – In comparison with the other models, deviations of the experimental model function from the raw data were minimal. The fit remained stable for time intervals between blood samples of up to 6 h. Conclusions – Due to its numerical stability, the function outlined in this study is suitable for large clinical reperfusion trials. In the case of uncomplicated infarctions without thrombolytic therapy, the area under the creatine kinase activity curve could be directly calculated in terms of maximum activity and time to peak. |
doi_str_mv | 10.1093/cvr/24.4.328 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79799315</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79799315</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-b8414989a6236c1628531985db5e87d6ca8c758bf9cfda02663d35819d975bca3</originalsourceid><addsrcrecordid>eNpdkU1v1DAQhiMEKtvCjSuSD4hTs43j-OsIFaWoRT3wIdSLNbEdMJvYwXZW7C_j7-Gyqz1wGs28j94ZzVtVL3Czxo0kF3obL9pu3a1JKx5VK8wprUnb0cfVqmkaUTPCyNPqNKWfpaWUdyfVSYuFpEyuqj93c3aTS9agYfE6u-DRECIyNts4Oe_8d1QAi3JAs4UN0tFCdt6ijfOQLAJv_p_VH98iSMgHXzu_heS2FkU72zgs6cHfeeM05BATgqGsQflHDFMfxl12ujQ2wrwrFAK9ZIumXdAQjYOxzAaI_458Vj0ZYEz2-aGeVV-u3n2-vK5v795_uHxzW2tCRK570eFOCgmsJUxj1gpKsBTU9NQKbpgGoTkV_SD1YKBpGSOGUIGlkZz2GshZ9XrvO8fwa7Epq_IsbccRvA1LUlxyKQmmBTzfgzqGlKId1BzdBHGncKMeclIlJ9V2qlMlp4K_PPgu_WTNET4EU_RXBx2ShnGI4LVLR6xjmDeMFKzeYy5l-_soQ9woxgmn6vrbvbpi7Vf66eZG3ZO_7m2vdw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79799315</pqid></control><display><type>article</type><title>Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Schwerdt, Holger ; Özbek, Cem ; Fröhlig, Gerd ; Schieffer, Hermann ; Bette, Ludwig</creator><creatorcontrib>Schwerdt, Holger ; Özbek, Cem ; Fröhlig, Gerd ; Schieffer, Hermann ; Bette, Ludwig</creatorcontrib><description>Study objective – The aim of the study was to investigate the use of an optimised function to approximate and interpolate the time course of serum creatine kinase and creatine kinase-MB values after thrombolytic therapy in acute myocardial infarction. Design – A three parameter interpolating function was developed which approximates the time course of serum enzyme levels. In the proposed function, time to peak creatine kinase and maximum of creatine kinase determined from raw data were used as starting parameters of the non-linear interpolation routine, thus providing ideal starting conditions for the iteration. The efficacy of the function was compared with that of three other functions cited in published reports (log-normal distribution function, modified gamma density function, three compartment function). Subjects – Serum enzyme data from 20 patients with acute myocardial infarction were used in the comparisons. The patients have all been treated with anisoylated plasminogen streptokinase activator complex. Results – In comparison with the other models, deviations of the experimental model function from the raw data were minimal. The fit remained stable for time intervals between blood samples of up to 6 h. Conclusions – Due to its numerical stability, the function outlined in this study is suitable for large clinical reperfusion trials. In the case of uncomplicated infarctions without thrombolytic therapy, the area under the creatine kinase activity curve could be directly calculated in terms of maximum activity and time to peak.</description><identifier>ISSN: 0008-6363</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/24.4.328</identifier><identifier>PMID: 2189569</identifier><identifier>CODEN: CVREAU</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>acute myocardial infarction ; Anistreplase ; Biological and medical sciences ; Cardiology. Vascular system ; Creatine Kinase - blood ; Fibrinolytic Agents - therapeutic use ; Humans ; Isoenzymes ; Mathematics ; Medical sciences ; model functions for enzyme activity curves ; Models, Biological ; Myocardial Infarction - drug therapy ; Myocardial Infarction - enzymology ; non-invasive reperfusion indicators ; Plasminogen - therapeutic use ; Streptokinase - therapeutic use ; Thrombolytic Therapy ; Time Factors ; time to peak creatine kinase</subject><ispartof>Cardiovascular research, 1990-04, Vol.24 (4), p.328-334</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c338t-b8414989a6236c1628531985db5e87d6ca8c758bf9cfda02663d35819d975bca3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4617063$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2189569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwerdt, Holger</creatorcontrib><creatorcontrib>Özbek, Cem</creatorcontrib><creatorcontrib>Fröhlig, Gerd</creatorcontrib><creatorcontrib>Schieffer, Hermann</creatorcontrib><creatorcontrib>Bette, Ludwig</creatorcontrib><title>Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>Study objective – The aim of the study was to investigate the use of an optimised function to approximate and interpolate the time course of serum creatine kinase and creatine kinase-MB values after thrombolytic therapy in acute myocardial infarction. Design – A three parameter interpolating function was developed which approximates the time course of serum enzyme levels. In the proposed function, time to peak creatine kinase and maximum of creatine kinase determined from raw data were used as starting parameters of the non-linear interpolation routine, thus providing ideal starting conditions for the iteration. The efficacy of the function was compared with that of three other functions cited in published reports (log-normal distribution function, modified gamma density function, three compartment function). Subjects – Serum enzyme data from 20 patients with acute myocardial infarction were used in the comparisons. The patients have all been treated with anisoylated plasminogen streptokinase activator complex. Results – In comparison with the other models, deviations of the experimental model function from the raw data were minimal. The fit remained stable for time intervals between blood samples of up to 6 h. Conclusions – Due to its numerical stability, the function outlined in this study is suitable for large clinical reperfusion trials. In the case of uncomplicated infarctions without thrombolytic therapy, the area under the creatine kinase activity curve could be directly calculated in terms of maximum activity and time to peak.</description><subject>acute myocardial infarction</subject><subject>Anistreplase</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Creatine Kinase - blood</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Humans</subject><subject>Isoenzymes</subject><subject>Mathematics</subject><subject>Medical sciences</subject><subject>model functions for enzyme activity curves</subject><subject>Models, Biological</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - enzymology</subject><subject>non-invasive reperfusion indicators</subject><subject>Plasminogen - therapeutic use</subject><subject>Streptokinase - therapeutic use</subject><subject>Thrombolytic Therapy</subject><subject>Time Factors</subject><subject>time to peak creatine kinase</subject><issn>0008-6363</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1v1DAQhiMEKtvCjSuSD4hTs43j-OsIFaWoRT3wIdSLNbEdMJvYwXZW7C_j7-Gyqz1wGs28j94ZzVtVL3Czxo0kF3obL9pu3a1JKx5VK8wprUnb0cfVqmkaUTPCyNPqNKWfpaWUdyfVSYuFpEyuqj93c3aTS9agYfE6u-DRECIyNts4Oe_8d1QAi3JAs4UN0tFCdt6ijfOQLAJv_p_VH98iSMgHXzu_heS2FkU72zgs6cHfeeM05BATgqGsQflHDFMfxl12ujQ2wrwrFAK9ZIumXdAQjYOxzAaI_458Vj0ZYEz2-aGeVV-u3n2-vK5v795_uHxzW2tCRK570eFOCgmsJUxj1gpKsBTU9NQKbpgGoTkV_SD1YKBpGSOGUIGlkZz2GshZ9XrvO8fwa7Epq_IsbccRvA1LUlxyKQmmBTzfgzqGlKId1BzdBHGncKMeclIlJ9V2qlMlp4K_PPgu_WTNET4EU_RXBx2ShnGI4LVLR6xjmDeMFKzeYy5l-_soQ9woxgmn6vrbvbpi7Vf66eZG3ZO_7m2vdw</recordid><startdate>199004</startdate><enddate>199004</enddate><creator>Schwerdt, Holger</creator><creator>Özbek, Cem</creator><creator>Fröhlig, Gerd</creator><creator>Schieffer, Hermann</creator><creator>Bette, Ludwig</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199004</creationdate><title>Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction</title><author>Schwerdt, Holger ; Özbek, Cem ; Fröhlig, Gerd ; Schieffer, Hermann ; Bette, Ludwig</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-b8414989a6236c1628531985db5e87d6ca8c758bf9cfda02663d35819d975bca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>acute myocardial infarction</topic><topic>Anistreplase</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Creatine Kinase - blood</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Humans</topic><topic>Isoenzymes</topic><topic>Mathematics</topic><topic>Medical sciences</topic><topic>model functions for enzyme activity curves</topic><topic>Models, Biological</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - enzymology</topic><topic>non-invasive reperfusion indicators</topic><topic>Plasminogen - therapeutic use</topic><topic>Streptokinase - therapeutic use</topic><topic>Thrombolytic Therapy</topic><topic>Time Factors</topic><topic>time to peak creatine kinase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwerdt, Holger</creatorcontrib><creatorcontrib>Özbek, Cem</creatorcontrib><creatorcontrib>Fröhlig, Gerd</creatorcontrib><creatorcontrib>Schieffer, Hermann</creatorcontrib><creatorcontrib>Bette, Ludwig</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwerdt, Holger</au><au>Özbek, Cem</au><au>Fröhlig, Gerd</au><au>Schieffer, Hermann</au><au>Bette, Ludwig</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>1990-04</date><risdate>1990</risdate><volume>24</volume><issue>4</issue><spage>328</spage><epage>334</epage><pages>328-334</pages><issn>0008-6363</issn><eissn>1755-3245</eissn><coden>CVREAU</coden><abstract>Study objective – The aim of the study was to investigate the use of an optimised function to approximate and interpolate the time course of serum creatine kinase and creatine kinase-MB values after thrombolytic therapy in acute myocardial infarction. Design – A three parameter interpolating function was developed which approximates the time course of serum enzyme levels. In the proposed function, time to peak creatine kinase and maximum of creatine kinase determined from raw data were used as starting parameters of the non-linear interpolation routine, thus providing ideal starting conditions for the iteration. The efficacy of the function was compared with that of three other functions cited in published reports (log-normal distribution function, modified gamma density function, three compartment function). Subjects – Serum enzyme data from 20 patients with acute myocardial infarction were used in the comparisons. The patients have all been treated with anisoylated plasminogen streptokinase activator complex. Results – In comparison with the other models, deviations of the experimental model function from the raw data were minimal. The fit remained stable for time intervals between blood samples of up to 6 h. Conclusions – Due to its numerical stability, the function outlined in this study is suitable for large clinical reperfusion trials. In the case of uncomplicated infarctions without thrombolytic therapy, the area under the creatine kinase activity curve could be directly calculated in terms of maximum activity and time to peak.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>2189569</pmid><doi>10.1093/cvr/24.4.328</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-6363 |
ispartof | Cardiovascular research, 1990-04, Vol.24 (4), p.328-334 |
issn | 0008-6363 1755-3245 |
language | eng |
recordid | cdi_proquest_miscellaneous_79799315 |
source | MEDLINE; Oxford University Press Journals Digital Archive Legacy |
subjects | acute myocardial infarction Anistreplase Biological and medical sciences Cardiology. Vascular system Creatine Kinase - blood Fibrinolytic Agents - therapeutic use Humans Isoenzymes Mathematics Medical sciences model functions for enzyme activity curves Models, Biological Myocardial Infarction - drug therapy Myocardial Infarction - enzymology non-invasive reperfusion indicators Plasminogen - therapeutic use Streptokinase - therapeutic use Thrombolytic Therapy Time Factors time to peak creatine kinase |
title | Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T13%3A34%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimised%20function%20for%20determining%20time%20to%20peak%20creatine%20kinase%20and%20creatine%20kinase-MB%20as%20non-invasive%20reperfusion%20indicators%20after%20thrombolytic%20therapy%20in%20acute%20myocardial%20infarction&rft.jtitle=Cardiovascular%20research&rft.au=Schwerdt,%20Holger&rft.date=1990-04&rft.volume=24&rft.issue=4&rft.spage=328&rft.epage=334&rft.pages=328-334&rft.issn=0008-6363&rft.eissn=1755-3245&rft.coden=CVREAU&rft_id=info:doi/10.1093/cvr/24.4.328&rft_dat=%3Cproquest_cross%3E79799315%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79799315&rft_id=info:pmid/2189569&rfr_iscdi=true |